Attendo AB (publ) (STO:ATT)
Sweden · Delayed Price · Currency is SEK 80.70
-0.40 (-0.49%)
Oct 31, 2025, 12:59 PM CET
Attendo AB Revenue
Attendo AB had revenue of 4.77B SEK in the quarter ending September 30, 2025, a decrease of -2.17%. This brings the company's revenue in the last twelve months to 19.07B, up 2.96% year-over-year. In the year 2024, Attendo AB had annual revenue of 18.98B with 9.79% growth.
Revenue (ttm)
19.07B
Revenue Growth
+2.96%
P/S Ratio
0.62
Revenue / Employee
577.97K
Employees
33,000
Market Cap
11.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.98B | 1.69B | 9.79% |
| Dec 31, 2023 | 17.29B | 2.79B | 19.25% |
| Dec 31, 2022 | 14.50B | 1.63B | 12.66% |
| Dec 31, 2021 | 12.87B | 579.00M | 4.71% |
| Dec 31, 2020 | 12.29B | 353.00M | 2.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Attendo AB News
- 9 days ago - Attendo AB (LTS:0RCY) Q3 2025 Earnings Call Highlights: Record Occupancy and Strong Finnish ... - GuruFocus
- 9 days ago - Q3 2025 Attendo AB (publ) Earnings Call Transcript - GuruFocus